$94.51
-1.16-1.21%
At close: Dec 5, 4:00 PM EST
$94.51
N/A
After Hours: 4:39 PM EST
Comments
Loading...
HealthEquity Stock Guidance | NASDAQ:HQY | Benzinga
HealthEquity issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
12/03/2025 | HQY | HealthEquity | FY | 2026 | $3.87 | $3.95 | $3.62 | $1.30B | $1.31B | $1.31B | |
09/02/2025 | HQY | HealthEquity | FY | 2026 | $3.74 | $3.91 | $3.48 | $1.29B | $1.31B | $1.30B | |
06/03/2025 | HQY | HealthEquity | FY | 2026 | $3.61 | $3.78 | $3.62 | $1.28B | $1.30B | $1.30B | |
03/18/2025 | HQY | HealthEquity | FY | 2026 | $3.57 | $3.74 | $3.76 | $1.28B | $1.30B | $1.31B | |
12/09/2024 | HQY | HealthEquity | FY | 2026 | — | — | — | $1.27B | $1.29B | $1.32B | |
12/09/2024 | HQY | HealthEquity | FY | 2025 | $3.08 | $3.16 | $3.12 | $1.19B | $1.20B | $1.18B | |
09/03/2024 | HQY | HealthEquity | FY | 2025 | $2.98 | $3.14 | $3.01 | $1.17B | $1.19B | $1.17B | |
06/03/2024 | HQY | HealthEquity | FY | 2025 | $2.93 | $3.10 | $2.90 | $1.16B | $1.18B | $1.16B | |
03/19/2024 | HQY | HealthEquity | FY | 2025 | $2.79 | $2.96 | $2.83 | $1.14B | $1.16B | $1.15B | |
02/21/2024 | HQY | HealthEquity | FY | 2024 | $2.20 | $2.24 | $2.14 | $995.00M | $1.00B | $992.74M | |
02/21/2024 | HQY | HealthEquity | FY | 2025 | — | — | — | $1.14B | $1.16B | $1.15B | |
12/05/2023 | HQY | HealthEquity | FY | 2025 | — | — | — | $1.14B | $1.16B | $1.13B | |
12/05/2023 | HQY | HealthEquity | FY | 2024 | $2.08 | $2.16 | $2.02 | $985.00M | $995.00M | $989.00M | |
09/05/2023 | HQY | HealthEquity | FY | 2024 | $1.97 | $2.06 | $1.92 | $980.00M | $990.00M | $981.07M | |
06/05/2023 | HQY | HealthEquity | FY | 2024 | $1.88 | $1.97 | $1.77 | $975.00M | $985.00M | $967.94M | |
03/21/2023 | HQY | HealthEquity | FY | 2024 | $1.74 | $1.87 | $1.77 | $960.00M | $975.00M | $961.58M | |
12/06/2022 | HQY | HealthEquity | FY | 2024 | — | — | — | $950.00M | $970.00M | $948.40M | |
12/06/2022 | HQY | HealthEquity | FY | 2023 | $1.26 | $1.35 | $1.27 | $850.00M | $860.00M | $839.50M | |
09/06/2022 | HQY | HealthEquity | FY | 2023 | $1.23 | $1.32 | $1.28 | $834.00M | $844.00M | $831.91M | |
06/06/2022 | HQY | HealthEquity | FY | 2023 | $1.23 | $1.32 | $1.27 | $827.00M | $837.00M | $826.16M | |
03/22/2022 | HQY | HealthEquity | FY | 2023 | $1.21 | $1.30 | $1.41 | $820.00M | $830.00M | $817.41M | |
02/22/2022 | HQY | HealthEquity | FY | 2023 | — | — | — | $815.00M | $830.00M | $827.36M | |
02/22/2022 | HQY | HealthEquity | FY | 2022 | $1.30 | $1.33 | $1.33 | $754.00M | $756.00M | $751.50M | |
12/06/2021 | HQY | HealthEquity | FY | 2022 | $1.30 | $1.35 | $1.48 | $750.00M | $755.00M | $762.28M |
FAQ
What is the most recent guidance for HealthEquity (HQY)?
The most recent guidance for HealthEquity (HQY) was reported on December 3, 2025 for the full year 2026. The company provided earnings per share guidance in the range of $3.87 to $3.95, compared to the estimated EPS of $3.62. Additionally, HealthEquity forecasted revenue between $1.30B and $1.31B for the quarter.
Browse guidance and forecast on all stocks.
